5:01 PM ET
10-Q
Financial Results
Bluejay Diagnostics Q3 2026 Results: Net Loss of $2.01M, Loss Widens
Bluejay Diagnostics reported a net loss of $6.26 million for the nine months ended September 30, 2026, compared to $5.42 million in the prior year period. The company strengthened its cash position to $7.38 million through private placements and warrant exercises, while continuing to invest heavily in research and development for its diagnostic platform.
- Key figure
- Net loss $2.01M